Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.
Summary
Bill A01720 aims to amend the insurance law and public health law in New York to establish patient safety and quality assurance measures concerning the distribution of patient-specific medications from insurer-designated pharmacies. It specifically prohibits practices known as "brown bagging" and "white bagging," where patients transport medications from pharmacies to healthcare providers for administration. The bill mandates that insurers must create agreements with healthcare providers to ensure proper handling and storage of medications before administration, including provisions for expedited processes, same-day delivery, and 24/7 access to pharmacists or nurses.
Impact
The bill will significantly impact how medications are distributed and administered in New York, particularly affecting insurers, pharmacies, and healthcare providers. By prohibiting certain distribution practices, it aims to enhance patient safety and ensure that medications are handled properly throughout the supply chain. This could lead to changes in existing contracts and policies between insurers and pharmacies, as well as adjustments in operational procedures for healthcare providers.
Sentiment
The general sentiment around Bill A01720 appears to be supportive, as it addresses important patient safety concerns regarding medication distribution. However, there may be some contention among stakeholders, particularly insurers and pharmacies, regarding the implications of the new requirements and the potential increase in operational responsibilities.
Contention
Notable points of contention include the potential burden placed on insurers and pharmacies to comply with the new requirements, particularly regarding the logistics of medication delivery and the establishment of agreements with healthcare providers. Some stakeholders may argue that these changes could lead to increased costs and administrative complexities, while proponents emphasize the importance of patient safety and quality assurance in medication administration.
Same As
Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.
Establishes patient safety and quality assurance measures regarding the distribution of patient-specific medication from an insurer-designated pharmacy; prohibits certain "brown bagging" and "white bagging" policies regarding pharmacy provided medications.